LYPHF Stock: Luye Pharma Group Ltd. Stock Price, Analysis & Insights
Get live LYPHF stock price $0.33, comprehensive Luye Pharma Group Ltd. stock analysis, charts, news, and expert forecast. Real-time LYPHF stock data and investment insights.
Loading chart data...
Luye Pharma Group Ltd. (LYPHF) Overview
Luye Pharma Group Ltd. (LYPHF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, LYPHF trades at $0.33 with a market capitalization of 1.31B . Over the past 52 weeks, LYPHF has traded between $0.27 and $0.40 , with the current price positioned at approximately 47% of this range . The stock cu...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 1.31B
- Current price: $0.33
- 52-week range: $0.27 - $0.40
- P/E ratio: 16.39
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Luye Pharma Group Ltd., serving as an investment holding company, engages in the global research, development, production, commercialization, and distribution of a diverse portfolio of pharmaceutical products. Their oncology treatments include Lipusu...
Company Information
- CEO
- Dian Bo Liu
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 5150
Contact Information
- Website
- https://www.luye.cn
- Address
- No. 15 Chuang Ye Road
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.4)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Luye Pharma Group Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Luye Pharma Group Ltd.
- ⚠Investors should consider how Luye Pharma Group Ltd. fits within their overall portfolio allocation
Market Cap
1.31B
P/E Ratio (TTM)
16.39
Beta
0.86
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LYPHF with peer companies:
- Price
- $3.50
- Market cap
- 624.32M
- Price
- $15.01
- Market cap
- 1.20B
- Price
- $24.23
- Market cap
- 1.89B
- Price
- $23.00
- Market cap
- 1.19B
- Price
- $33.66
- Market cap
- 1.74B
- Price
- $1.00
- Market cap
- 758.42M
- Price
- $83.00
- Market cap
- 1.56B
- Price
- $26.00
- Market cap
- 984.58M
- Price
- $0.33
- Market cap
- 839.59M
- Price
- $1.72
- Market cap
- 601.91M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.